Treatment with a PAD4 inhibitor or DNase I overcame neutrophil-dependent chemoresistance, but had no effect on the number of tumor cells in mice not given chemotherapy, while in vitro inhibition of PAD4 improved the efficacy of chemotherapy. The gene discussed is DNASE1L3; the disease is neoplasm.